BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$10.32
0.54 (5.52%)
▲
5d:
+13.41%
30d:
+15.31%
90d:
-36.76%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Sep 14, 2026
19d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BNR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BNR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $10.32, which is considered extended relative to its 30-day fair value range of $8.83 to $9.95.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.83, while resistance sits at $11.13. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: BNR scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.83, while resistance sits at $11.13. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: BNR scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.83 -
$9.95
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.5%)
- BEARISH: Trading 60.9% above Wall St target ($4.03)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.83 -
$9.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.83
Resistance Level
$11.13
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Wall Street Target
$4.03
(-60.9%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: August 24, 2026 11:18 PM ET
Data refreshes hourly during market hours. Next update: 12:18 AM
Data refreshes hourly during market hours. Next update: 12:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 44 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 37 SELL |
